Summit Partners Public Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-40,000
Closed -$5.83M 131
2017
Q3
$5.83M Hold
40,000
0.79% 46
2017
Q2
$5.2M Sell
40,000
-45,000
-53% -$5.51M 0.71% 56
2017
Q1
$10.6M Buy
85,000
+30,000
+55% +$3.59M 2.05% 15
2016
Q4
$6.37M Buy
+55,000
New +$6.13M 1.36% 26
2016
Q3
Sell
-80,000
Closed -$8.66M 133
2016
Q2
$7.89M Buy
80,000
+35,000
+78% +$3.62M 1.43% 21
2016
Q1
$4.5M Buy
45,000
+15,000
+50% +$1.54M 0.95% 31
2015
Q4
$3.59M Buy
+30,000
New +$3.47M 0.93% 42

Other funds holding CELG

Summit Partners Public Asset Management's CELG Position: Q4 2017 in Review

Summit Partners Public Asset Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 40,000 shares — an estimated $5.83M sold.

Summit Partners Public Asset Management first reported a position in CELG in Q4 2015 and held it in 7 quarters. The position peaked at $10.6M in Q1 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Summit Partners Public Asset Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 40,000 Celgene Corp shares in Q4 2017, an estimated $5.83M.
  • Summit Partners Public Asset Management first reported a position in Celgene Corp in Q4 2015 and held it in 7 quarters.
  • Summit Partners Public Asset Management's Celgene Corp position peaked at $10.6M in Q1 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.